Captopril, a powerful angiotensin-converting enzyme (ACE) inhibitor, has shown to be a essential therapeutic agent in the management of hypertension and other cardiovascular disorders. Its mechanism of action involves selectively inhibiting the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor. This results in vasodilation and